| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/12/2004 | US20040157219 comprises an alkaline agent, at least one detergent, and a suspension of paramagnetic particles and an acidic solution |
| 08/12/2004 | US20040157218 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 08/12/2004 | US20040157217 comprises a bifunctional linker, an intercalating agent or a minor groove binder; for solid phase synthesis |
| 08/12/2004 | US20040157216 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 08/12/2004 | US20040157213 Fungal reverse transcriptases with enhanced capabilities |
| 08/12/2004 | US20040156854 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 08/12/2004 | US20040154932 Methods of determining the concentration of an analyte in a fluid test sample |
| 08/12/2004 | DE10304448A1 Fluorimetrische Bestimmung von Analyten durch Amin-N-Oxide als Redoxindikatoren Fluorimetric determination of analytes by amine-N-oxides as redox indicators |
| 08/12/2004 | DE10303850A1 Screening-Assay auf Basis des Forkhead-Transkriptionsfaktor-abhängigen sod-3-Promotors zur Identifizierung von AKT modulierenden Verbindungen oder von stromaufwärts liegenden Regulatoren, wie etwa Insulin/IGF1-Rezeptoren Screening assay based on the Forkhead transcription factor-dependent SOD-3 promoter used to identify AKT modulating compounds or of upstream regulators, such as insulin / IGF1 receptors |
| 08/12/2004 | DE10258398A1 Verfahren zur Amplifikation von DNA A method for amplifying DNA |
| 08/12/2004 | CA2514950A1 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
| 08/12/2004 | CA2514877A1 Assay method for group transfer reactions |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2514443A1 The method of detecting the cacna1h mutant gene of childhood absence epilepsy-the main function gene, and the cacna1h mutant gene |
| 08/12/2004 | CA2514396A1 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 08/12/2004 | CA2514327A1 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/12/2004 | CA2514187A1 Expression profiles for colon cancer and methods of use |
| 08/12/2004 | CA2514180A1 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 08/12/2004 | CA2514066A1 Sensitive proteasome sensor constructs and methods for their design and use |
| 08/12/2004 | CA2514062A1 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | CA2513747A1 Methods of predicting mortality risk by determining telomere length |
| 08/12/2004 | CA2513615A1 Facls as modifiers of the rb pathway and methods of use |
| 08/12/2004 | CA2513601A1 Tkts as modifiers of the beta-catenin pathway and methods of use |
| 08/12/2004 | CA2513590A1 Production of 5'-ribonucleotides |
| 08/12/2004 | CA2513398A1 Antisense oligonucleotides that inhibit expression of hif-1 |
| 08/12/2004 | CA2513191A1 Methods and compositions for analysis of mitochondrial-related gene expression |
| 08/12/2004 | CA2513159A1 Method for the detection of cytosine methylation patterns with high sensitivity |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/12/2004 | CA2457607A1 Method of mutagenic chain reaction |
| 08/11/2004 | EP1445609A1 Base sequencing electrode, base sequencing device and base sequencing method |
| 08/11/2004 | EP1445605A1 Biosensor |
| 08/11/2004 | EP1445603A1 Fluorometric Determination of Analytes with Amine-N-Oxides as Redox-Indicators |
| 08/11/2004 | EP1445602A1 Fluorimetric Determination of an Analyte by an Intramolecular Quencher-Fluorophore-Conjugate |
| 08/11/2004 | EP1445333A2 Screening of a novel hepatic syndrome and its uses |
| 08/11/2004 | EP1445332A1 E. coli 0145 specific sequences and their uses |
| 08/11/2004 | EP1445331A1 Molecular biological identification techniques for microorganism |
| 08/11/2004 | EP1445330A1 Probe medium and method of producing the same |
| 08/11/2004 | EP1445329A2 Method and test strip for determining glucose in blood |
| 08/11/2004 | EP1445328A1 Atp measurement method allowing visual judgement and reagent therefor |
| 08/11/2004 | EP1445327A1 Method of screening drug acting on cell wall |
| 08/11/2004 | EP1445319A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 08/11/2004 | EP1445318A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2004 | EP1445317A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2004 | EP1445313A1 METHOD OF DETECTING AND QUANTIFYING HEMOLYSIN-PRODUCING BACTERIA BY OVERWHELMINGLY DETECTING AND QUANTIFYING THERMOSTABLE HEMOLYSIN-RELATED GENES (tdh-RELATED HEMOLYSIN GENES) OF FOOD POISONING BACTERIA |
| 08/11/2004 | EP1444890A1 RS1 deficient transgenic animal and uses thereof |
| 08/11/2004 | EP1444525A2 Bag-1 mediated down-regulation of glucocorticoid-receptor transactivation |
| 08/11/2004 | EP1444524A2 Methods for the identification of modulators of magnesium chelatase expression or activity in plants |
| 08/11/2004 | EP1444523A2 Screening for hepatitis c virus entry inhibitors |
| 08/11/2004 | EP1444522A2 Screening for antiviral agents affecting signal peptidase |
| 08/11/2004 | EP1444521A1 Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance |
| 08/11/2004 | EP1444520A2 Methods for monitoring amyotrophic lateral sclerosis |
| 08/11/2004 | EP1444517A2 Assay based on doped nanoparticles |
| 08/11/2004 | EP1444500A2 Microwell biochip |
| 08/11/2004 | EP1444365A2 Asymmetric pcr with nuclease-free polymerase or nuclease-resistant molecular beacons |
| 08/11/2004 | EP1444364A2 Multiple oligonucleotides per gene for use in gene arrays |
| 08/11/2004 | EP1444363A1 Transfection kinetics and structural promoters |
| 08/11/2004 | EP1444362A2 High-throughput transcriptome and functional validation analysis |
| 08/11/2004 | EP1444361A2 Classification of lung carcinomas using gene expression analysis |
| 08/11/2004 | EP1444360A2 Sequence variants of the human growth hormone gene and methods for detection |
| 08/11/2004 | EP1444359A2 Assay for phospholipid transfer protein (pltp) activity |
| 08/11/2004 | EP1444358A2 Method for characterising and/or identifying active mechanisms of antimicrobial test substances |
| 08/11/2004 | EP1444357A2 Method for detecting macromolecular biopolymers using at least one unit for immobilizing macromolecular biopolymers and a biosensor for detecting macromolecular biopolymers |
| 08/11/2004 | EP1444355A2 Nucleic acid amplification |
| 08/11/2004 | EP1444347A2 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 08/11/2004 | EP1444346A2 Sirna knockout assay method and constructs |
| 08/11/2004 | EP1444341A2 Rankl mimics and uses thereof |
| 08/11/2004 | EP1444331A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 08/11/2004 | EP1444329A2 Stem cells that transform to beating cardiomyocytes |
| 08/11/2004 | EP1444328A2 Induction of beta cell differentiation in human cells |
| 08/11/2004 | EP1444326A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444262A2 Growth hormone variations in humans and their uses |
| 08/11/2004 | EP1444259A2 Adenylate cyclase with additional ion channel domain |
| 08/11/2004 | EP1444254A2 Molecules for disease detection and treatment |
| 08/11/2004 | EP1444245A2 Novel chromophores/fluorophores and methods for using the same |
| 08/11/2004 | EP1444204A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 08/11/2004 | EP1444034A2 Arrays having clustered arrangements and methods of making and using them |
| 08/11/2004 | EP1443973A2 Kits and methods for determining the effectiveness of sterilization or disinfection processes |
| 08/11/2004 | EP1443951A2 Molecular interactions in cells |
| 08/11/2004 | EP1443913A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1399582A4 Method for kidney disease detection by protein profiling |
| 08/11/2004 | EP1384068A4 Methods for determining secondary modifications of molecules using arrays |
| 08/11/2004 | EP1326881A4 PREPARATION OF CAPPED mRNA |
| 08/11/2004 | EP1287158B1 Screening system for antibiotics |
| 08/11/2004 | EP1242457B1 Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| 08/11/2004 | EP1226437B1 Cantilever sensors and transducers |
| 08/11/2004 | EP1212609B1 Low interference disposable sensor and method of making |
| 08/11/2004 | EP1116036B1 Water-soluble fluorescent semiconductor nanocrystals |
| 08/11/2004 | EP1042471B1 Mammalian edg-7 receptor homologs |
| 08/11/2004 | EP1012344A4 Non-competitive co-amplification methods |
| 08/11/2004 | EP1012329A4 Diagnosis and treatment of myocardial failure |
| 08/11/2004 | EP1009802B1 Methods for analyzimg polymers |
| 08/11/2004 | EP0977884B1 Test device and method |
| 08/11/2004 | EP0879412A4 Enzyme detection biosensors |
| 08/11/2004 | EP0862627B1 Neuropeptide y-y5 receptor |
| 08/11/2004 | EP0804453A4 Method for detection and treatment of breast cancer |
| 08/11/2004 | EP0749472B1 Extracorporeal cell culture and transplantation kits |
| 08/11/2004 | EP0730648B1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 08/11/2004 | EP0629132B1 Purified vacuolating toxin from helicobacter pylori and methods to use same |